跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACTEMRA 20 MG/ML Solution for injection/infusion - SFDA Drug Approval Details
Approvals
/
SFDA
/
ACTEMRA 20 MG/ML Solution for injection/infusion
Authorized
NCE
ACTEMRA 20 MG/ML Solution for injection/infusion
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
aa0d0b437d8684a9
Company
Unknown
Type
NCE
Approval Details
Approval Id
aa0d0b437d8684a9
Drug Approval Sfda Name
ACTEMRA 20 MG/ML Solution for injection/infusion
Trade Name
ACTEMRA 20 MG/ML Solution for injection/infusion
Generic Name
TOCILIZUMAB
Register Number
273-24-14
Register Year
2014
Drug Type
NCE
Route Of Administration
Intravenous use
Package Type
Vial
Package Size
1
Size
20
Size Unit
ml
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
store in a refrigerator (2°c – 8°c)
Shelf Life
30 Months
Distribution Site
Hospital
Description Code
7000001253-20-100000073870
Price
2936.4
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
aa0d0b437d8684a9
Type
NCE
Back to SFDA Approvals
